Insight that Drives the Boardroom

Stay ahead with data-backed research, governance analysis, and expert commentary for investors, activists, and corporate leaders.

Activism & Governance

SPAC Market Review – March 2022

Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.

SPAC & IPO Analysis

Daily SPAC Update – September 6, 2024

CDAQ + EEW Renewables and EVGR + Forekast Deals Announced. Vine Hill (VCIC) and Andretti (POLE) $200M SPAC IPOs. PPHP Extension Approved. XFIN Deal Vote Set.

Daily SPAC Update – September 5, 2024

KVAC + Medera Deal Announced. IRAA Extension Vote. ACAB and RFAC Set Extension Votes. Merger Agreements for DECA, CCTS and ACAB Amendment. CLOE Vote Postponed (again).

Daily SPAC Update – September 4, 2024

DECA + Semnur Pharmaceuticals Deal. MITA and SKGR Extension Votes Set. IFIN DeSPAC. APXI Removes MultiplAI from Deal. GLLI PIPE. DYCQ LOI Announced.

Daily SPAC Update – September 3, 2024

Aspire Biopharma+PowerUp Acquisition Deal. TRTLF Deal Termination Becomes Mutual. MCAG Merger Agreement. NNAG Deal Termination. FIAC / DevvStream Deal Deck. SBXC Extension Approved.

Daily SPAC Update – August 30, 2024

Gigcapital7 $250M IPO. SPAC Deals: CCTS + Tembo, ANSC + Australian Food and Agriculture, MCAG + CUBEBIO. LPAA Separate Trading. PTWO Deal Approved.

Get it In Your Inbox

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.